Alzheimer's disease—the most common form of dementia—is a progressive neurological disorder that causes brain cells to ...

The loss of companionship is perhaps the initial beginning of relationship changes. The partner, now assuming a caregiver ...

Dr. Joanne Pike, CEO of the Alzheimer's Association, talks about the challenges and hopes when it comes to this debilitating ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

A new study finds that brain shrinkage in Alzheimer’s disease varies greatly among individuals, with distinct patterns rather ...

HUNTSVILLE, Ala ( WHNT) — November is Alzheimer’s Awareness Month. “The disease touches everybody in the patient’s world,” ...

That Thursday, for the first time, the European Medicines Agency (EMA) approved a drug that targets the cause — not just the ...

The last of three walks to end Alzheimer’s is wrapping up this weekend. November is Alzheimer's Awareness Month across the ...

The European Union's drugs regulator on Thursday recommended approval of Eisai and Biogen's Leqembi for some patients with ...

More than 1,100 residents from across Sarasota-Manatee showed their support during the annual fundraiser at Nathan Benderson ...

Using cerebrospinal fluid from living patients, researchers have identified specific proteins and genetic pathways involved ...

Researchers have created a highly detailed cellular map of Alzheimer’s disease progression, revealing new insights into the ...